PresbiDrops (CSF-1)

DRUG2 trials

Sponsors

Orasis Pharmaceuticals Ltd.

Conditions

Presbyopia

Phase 2

Safety, Tolerability, and Efficacy of PresbiDrops (CSF-1), a Topical Ophthalmic Drug for Presbyopia

CompletedNCT02745223

Orasis Pharmaceuticals Ltd.Presbyopia

Start: 2016-07-31End: 2017-06-30Updated: 2017-08-01

Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects

CompletedNCT02965664

Orasis Pharmaceuticals Ltd.Presbyopia

Start: 2016-12-31End: 2017-04-30Updated: 2017-08-01